Business | Wednesday May 8, 2013
Ranbaxy Laboratories, India's largest drugmaker by sales, reported a 90 per cent drop in first quarter net profit compared to the same year-ago period, when it had exclusive rights to a generic version of cholesterol lowering drug Lipitor in the United States.
www.ndtv.com/business